Clinical Trials Browser

Observational × neratinib × 1 year × Clear all

NCT04388384 2025-08-06

ELEANOR

Breast Neoplasms

NCT07019272 2025-06-13

Neratinib in Extended Adjuvant Treatment for HER2+ Early Breast Cancer With pCR But High-Risk Features: A Hebei Multi-Center Real-World Study

Not yet recruiting

HER2-positive Breast Cancer